Original Research
Published on 23 Aug 2024
‘Risk-benefit’ assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors
in Ethnopharmacology
- 8,235 views
- 2 citations












